AG
ABBV icon

Ascent Group’s AbbVie ABBV Stock Holding History

Ascent Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.26M Buy
33,359
+74
+0.2% +$16.4K 0.25% 86
2025
Q4 		$7.61M Buy
33,285
+1,024
+3% +$233K 0.26% 82
2025
Q3 		$7.47M Buy
32,261
+10,640
+49% +$2.17M 0.26% 81
2025
Q2 		$4.01M Sell
21,621
-2,955
-12% -$549K 0.16% 135
2025
Q1 		$5.15M Sell
24,576
-1,360
-5% -$264K 0.22% 97
2024
Q4 		$4.61M Buy
25,936
+1,389
+6% +$255K 0.35% 69
2024
Q3 		$4.85M Sell
24,547
-1,231
-5% -$230K 0.37% 62
2024
Q2 		$4.42M Buy
25,778
+1,102
+4% +$183K 0.36% 64
2024
Q1 		$4.49M Buy
24,676
+7,787
+46% +$1.34M 0.4% 55
2023
Q4 		$2.92M Buy
16,889
+1,819
+12% +$265K 0.28% 90
2023
Q3 		$2.08M Sell
15,070
-7,787
-34% -$1.14M 0.23% 123
2023
Q2 		$3.42M Buy
22,857
+1,257
+6% +$184K 0.38% 64
2023
Q1 		$3.44M Buy
21,600
+11,667
+117% +$1.78M 0.37% 64
2022
Q4 		$1.61M Buy
9,933
+973
+11% +$149K 0.19% 163
2022
Q3 		$1.31M Buy
8,960
+4,780
+114% +$686K 0.16% 177
2022
Q2 		$600K Buy
4,180
+949
+29% +$145K 0.07% 269
2022
Q1 		$524K Buy
3,231
+246
+8% +$35.7K 0.06% 293
2021
Q4 		$394K Buy
+2,985
New +$353K 0.05% 339

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ascent Group's ABBV Position: Q1 2026 in Review

Ascent Group increased its AbbVie (ABBV) stake by 0.22% in Q1 2026, buying an estimated $16.4K and bringing the position to 33,359 shares worth $7.26M. The position accounts for 0.25% of the portfolio, ranked #86.

Ascent Group first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $7.61M in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Ascent Group held 33,359 shares of AbbVie worth $7.26M as of Q1 2026.
  • Ascent Group bought 74 AbbVie shares in Q1 2026, an estimated $16.4K.
  • AbbVie made up 0.25% of Ascent Group's portfolio in Q1 2026, its #86 holding.
  • Ascent Group first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Ascent Group's AbbVie position peaked at $7.61M in Q4 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.